Steven K. Burke - 27 Feb 2023 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
SVP, Chief Medical Officer
Signature
/s/ Carolyn Rucci, attorney-in-fact for Steven K. Burke
Issuer symbol
AKBA
Transactions as of
27 Feb 2023
Net transactions value
-$6,131
Form type
4
Filing time
01 Mar 2023, 15:06:40 UTC
Previous filing
02 Feb 2023
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale $6,131 -7,539 -1.2% $0.8132 608,177 27 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.